Biogen (BIIB) Revenue (2009 - 2026)
Biogen (BIIB) posted quarterly Revenue of $2.7 billion for Q2 2026, up 3.42% year-over-year from $2.6 billion in Q2 2025, and up 10.42% quarter-over-quarter from $2.5 billion in Q1 2026.
Biogen (BIIB) Revenue (2009 - 2026) Analysis & Trends
Biogen's Revenue history runs 18 years deep, the most recent figure standing at $2.7 billion for Q2 2026.
- In Q2 2026, Revenue rose 3.42% year-over-year to $2.7 billion; the TTM figure through Jun 2026 stood at $10.0 billion (changed 0.31% YoY), while the FY2025 annual figure was $9.9 billion, up 2.22% from the prior year.
- Revenue for Q2 2026 stood at $2.7 billion, up from $2.5 billion in the prior quarter.
- The five-year high for Revenue was $2.7 billion in Q2 2026, with the low at $2.3 billion in Q4 2025.
- The 5-year median for Revenue is $2.5 billion (2024), against an average of $2.5 billion.
- The sharpest annual moves came in 2022 and 2025: Revenue decreased 9.73% in 2022, then climbed 7.33% in 2025.
- Biogen's Revenue stood at $2.5 billion in 2022, then declined by 6.2% to $2.4 billion in 2023, then rose by 2.87% to $2.5 billion in 2024, then retreated by 7.14% to $2.3 billion in 2025, then increased by 20.03% to $2.7 billion in 2026.
- Business Quant data shows BIIB's Revenue at $2.7 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 2.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Bn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 2.28 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.65 Bn |
| Mar 31, 2025 | 2.43 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 2.47 Bn |
| Jun 30, 2024 | 2.46 Bn |
| Mar 31, 2024 | 2.29 Bn |
| Dec 31, 2023 | 2.39 Bn |
| Sep 30, 2023 | 2.53 Bn |
| Jun 30, 2023 | 2.46 Bn |
| Mar 31, 2023 | 2.46 Bn |
| Dec 31, 2022 | 2.54 Bn |
| Sep 30, 2022 | 2.51 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 2.53 Bn |
| Dec 31, 2021 | 2.73 Bn |
| Sep 30, 2021 | 2.78 Bn |